Workflow
Alto Ingredients(ALTO)
icon
Search documents
Alto Ingredients, Inc. Reports Third Quarter 2025 Results
Globenewswire· 2025-11-05 21:05
Core Insights - Alto Ingredients, Inc. reported significant financial improvements in Q3 2025, with gross profit of $23 million, net income of $14 million, and adjusted EBITDA of $21 million, reflecting a strong performance across all business segments [1][2][4]. Financial Performance - Gross profit increased by $18 million compared to Q3 2024, reaching $23 million [1][2]. - Net income improved by $17 million, totaling $14 million or $0.19 per share, compared to a net loss of $2.8 million in the same quarter last year [1][8]. - Adjusted EBITDA grew by $9 million to $21 million compared to Q3 2024 [1][2]. Sales and Revenue - Net sales for Q3 2025 were $241 million, down from $251.8 million in Q3 2024 [8]. - Cost of goods sold decreased to $217.5 million from $245.9 million, contributing to improved gross profit margins [8]. - For the nine months ended September 30, 2025, net sales were $686 million, compared to $728.9 million in the same period of 2024 [8]. Operational Highlights - The company has focused on targeting high-return market segments and enhancing operational efficiency, which has positively impacted financial results [2][3]. - Increased renewable fuel export sales and higher demand for liquid CO2 were key drivers of growth [2][3]. - The company is expanding its CO2 utilization through the 2025 Carbonic acquisition to meet growing demand [3]. Cash and Liquidity - Cash and cash equivalents as of September 30, 2025, were $32.5 million, down from $35.5 million at the end of 2024 [6]. - The company had borrowing availability of $85 million, including $20 million under its operating line of credit and $65 million under its term loan facility [6]. Segment Performance - The Pekin Campus produced 31.6 million gallons of renewable fuel in Q3 2025, slightly up from 31.1 million gallons in Q3 2024 [23]. - Total renewable fuel gallons sold decreased to 66.8 million from 74.3 million year-over-year [23]. - Specialty alcohol sales remained stable, with 22.4 million gallons sold in Q3 2025 compared to 22.5 million gallons in Q3 2024 [23].
Alto Ingredients, Inc. to Release Third Quarter 2025 Financial Results on November 5, 2025
Globenewswire· 2025-10-29 12:30
Core Points - Alto Ingredients, Inc. will release its third quarter 2025 financial results on November 5, 2025, after market close [1] - A conference call will be held at 2:00 p.m. Pacific Time / 5:00 p.m. Eastern Time, featuring prepared remarks and a Q&A session [1] - The webcast will be archived for one year on the company's website [2] Company Overview - Alto Ingredients, Inc. is a leading producer and distributor of specialty alcohols, renewable fuels, and essential ingredients [3] - The company serves a diverse range of markets including Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels [3] - More information about the company can be found on its website [3]
Alto Ingredients, Inc. (ALTO) Presents at LD Micro Main Event XIX Investor Conference - Slideshow (NASDAQ:ALTO) 2025-10-22
Seeking Alpha· 2025-10-22 12:52
Group 1 - The article does not provide any specific information or insights regarding a company or industry [1]
Alto Ingredients (NasdaqCM:ALTO) Conference Transcript
2025-10-21 21:02
Summary of Alto Ingredients Conference Call - October 21, 2025 Company Overview - **Company**: Alto Ingredients (NasdaqCM:ALTO) - **Industry**: Renewable fuels, ethanol production, and related products Key Points and Arguments Company Evolution and Strategy - Alto Ingredients began as a small ethanol brokering firm 25 years ago and evolved into a renewable fuel ethanol producer with multiple plants on the West Coast [5][6] - The company faced challenges due to increased corn costs, leading to the sale of two California facilities and idling the Burley, Idaho plant [6][8] - A shift towards high protein and corn oil expansion technology was initiated, but market conditions led to idling the facility [7][9] - The acquisition of a liquid CO2 processing facility has stabilized earnings and contributed positively to the portfolio [10][12] Diversification and Product Portfolio - Alto Ingredients diversified its operations by acquiring plants in the Midwest, allowing entry into various markets such as industrial, pharmaceutical, and beverage [11][12] - The PEAKIN campus includes facilities capable of producing renewable fuels, high-quality alcohols, and various protein products, enhancing product mix and market flexibility [12][13] - The company rebranded in 2021 to reflect its broader product offerings beyond ethanol [13] Financial Performance and Cost Management - The company has focused on improving profitability by reducing expenses, including an $8 million annual reduction through staffing adjustments [14] - Integration of Eagle Alcohol's distribution center with Kennergy marketing segment has eliminated redundancies and improved customer service [15] Growth Opportunities - CO2 utilization is a significant growth opportunity, with the Columbia facility capable of processing 170,000 tons of CO2 annually [16][17] - Regulatory changes, such as the 45Z tax credits, are expected to enhance profitability, with potential earnings of $4 million to $8 million from the Columbia facility starting in 2025 [22][23] - The shift to E15 blends could increase demand for ethanol by 50%, providing a substantial market opportunity [25][26] Regulatory Environment - Positive regulatory changes, including support for E15 and 45Z credits, are seen as tailwinds for the industry [21][25] - The company is assessing the impact of recent regulations on carbon capture projects, particularly in Illinois [20][30] Market Dynamics - The demand for CO2 is increasing, particularly in the beverage sector, with limited competition in the West Coast market [31] - The company is exploring opportunities to maximize the value of its CO2 production through investments in capture and compression equipment [18][19] Additional Important Information - The company has shifted production focus from renewable fuels to high-quality alcohols, which currently yield higher margins [29] - Alto Ingredients is dedicated to operational excellence and strategic diversification to capture market opportunities [29] This summary encapsulates the key insights from the conference call, highlighting the company's strategic direction, financial performance, growth opportunities, and the regulatory landscape affecting its operations.
Alto Neuroscience Announces Plans to Accelerate Development of ALTO-207 in Treatment Resistant Depression Following Successful Outcome from Recent FDA Meeting
Businesswire· 2025-10-20 11:01
Core Insights - Alto Neuroscience, Inc. is accelerating the development of ALTO-207 for treatment-resistant depression (TRD) following a successful FDA meeting [1] - The company announced a $50 million private placement to support the expanded development of ALTO-207 [1] Company Overview - Alto Neuroscience is a clinical-stage biopharmaceutical company focused on developing novel precision medicines for neuropsychiatric disorders [1] Financial Aspects - The recent $50 million private placement will facilitate the advancement of ALTO-207 [1]
ALTO ALERT: Bragar Eagel & Squire, P.C. is Investigating Alto Neuroscience, Inc. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Globenewswire· 2025-10-07 22:05
Core Viewpoint - Bragar Eagel & Squire, P.C. is investigating potential claims against Alto Neuroscience, Inc. (NYSE:ANRO) on behalf of long-term stockholders due to a class action complaint alleging breaches of fiduciary duties by the board of directors [1][6]. Company Overview - Alto Neuroscience, Inc. is facing scrutiny following a class action complaint filed on July 21, 2025, concerning the period from February 2, 2024, to October 22, 2024 [1]. - The complaint alleges that the Offering Documents related to Alto's IPO were negligently prepared and that the effectiveness of ALTO-100 in treating Major Depressive Disorder (MDD) was overstated [6]. Financial Impact - On October 22, 2024, Alto announced that ALTO-100 did not meet its primary endpoint in a Phase 2b trial for MDD, leading to a significant stock price drop of $10.17 per share, or 69.99%, closing at $4.36 per share on October 23, 2024 [6].
Alto Ingredients, Inc. to Present in the LD Micro Main Event XIX
Globenewswire· 2025-10-07 12:30
Core Viewpoint - Alto Ingredients, Inc. is actively engaging with investors by participating in the LD Micro Main Event XIX, indicating a focus on investor relations and market presence [1]. Company Overview - Alto Ingredients, Inc. (NASDAQ: ALTO) is a prominent producer and distributor of specialty alcohols, renewable fuels, and essential ingredients [2]. - The company serves a diverse range of markets, including Health, Home & Beauty; Food & Beverage; Industry & Agriculture; Essential Ingredients; and Renewable Fuels [2]. Event Participation - Management plans to present at the LD Micro Main Event XIX on October 21, 2025, at 1:00 pm PT, and will also conduct one-on-one meetings with investors [1]. - Presentation materials and a webcast will be available on the company's website [1].
Alto Ingredients Applauds Passage of Assembly Bill 30 Expanding E15 Fuel Options in California
Globenewswire· 2025-10-06 12:30
Core Insights - Alto Ingredients, Inc. welcomes the signing of Assembly Bill 30, which authorizes the sale of E15 fuel in California, enabling the company to meet the rising demand for affordable, domestically produced ethanol blends while supporting clean energy goals [1][2][3] Company Positioning - With the approval of E15 fuel sales, ethanol consumption in California could increase by over 600 million gallons annually, positioning Alto Ingredients to leverage its production capacity of up to 350 million gallons of low carbon ethanol [2] - The CEO of Alto Ingredients commended the legislation for expanding consumer choice and promoting lower-carbon fuel options, indicating that it validates the role of American ethanol and encourages investment in infrastructure and job creation [3] Industry Impact - The legislation is expected to support California's evolving low carbon transportation fuels market, aligning with the state's ambitious climate objectives [1][2][3]
Alto Ingredients, Inc. (ALTO) Presents at H.C. Wainwright 27th Annual Global Investment Conference - Slideshow (NASDAQ:ALTO)
Seeking Alpha· 2025-09-09 17:31
Group 1 - The company is responsible for the development of transcript-related projects and publishes thousands of quarterly earnings calls each quarter [1] - The coverage of transcript-related content is continuing to grow and expand [1] - The purpose of the profile is to share new developments related to transcripts with readers [1]
Alto Ingredients, Inc. to Present in the 27th Annual H.C. Wainwright Global Investment Conference
Globenewswire· 2025-09-02 20:05
Core Insights - Alto Ingredients, Inc. is set to participate in the H.C. Wainwright 27th Annual Global Investment Conference on September 9, 2025, in New York City [1] - The company will conduct one-on-one meetings and present at 9:00 am ET, with presentation materials and webcast available on their website [2] Company Overview - Alto Ingredients, Inc. is a leading producer and distributor of specialty alcohols, renewable fuels, and essential ingredients, serving various markets including Health, Home & Beauty, Food & Beverage, Industry & Agriculture, Essential Ingredients, and Renewable Fuels [3]